We have recently selected MAbs specific for different molecular forms of the TCR gammddelta (expressed by distinct cell subsets), able to activate TCR gamma/delta+ cells. Two of these reagents (GI and Al3) were used for the construction of bispecific MAbs in conjunction with a MAb (Mov 19) directed
β¦ LIBER β¦
Targeting of T lymphocytes against egf-receptor+ tumor cells by bispecific monoclonal antibodies: Requirement of CD3 molecule cross-linking for t-cell activation
β Scribed by Silvano Ferrini; Anna Cambiaggi; Sabrina Sforzini; Sabrina Marciano; Silvana Canevari; Delia Mezzanzanica; Maria Ines Colnaghi; Carlo Enrico Grossi; Lorenzo Moretta
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- French
- Weight
- 835 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Retargeting of T-cell-receptor gamma/del
β
Silvano Ferrini; Ignazia Prigione; Serafina Mammoliti; Maria Ines Colnaghi; Sylv
π
Article
π
1989
π
John Wiley and Sons
π
French
β 307 KB
The role of lymphocyte subsets and adhes
β
Christoph Renner; Wolfram Jung; Ugur Sahin; Rene van Lier; Michael Pfreundschuh
π
Article
π
1995
π
John Wiley and Sons
π
English
β 776 KB
## Abstract The cure of human Hodgkin's tumors heterotransplanted into SCID mice can be achieved by two bispecific monoclonal antibodies (BiβmAb) directed against the tumorβassociated CD30 antigen and CD3 and CD28, respectively, and normal peripheral human blood T cells. We investigated the role of
Re-targeting of human lymphocytes expres
β
Silvano Ferrini; Ignazia Prigione; Serafina Mammouti; Maria Ines Colnaghi; Sylvi
π
Article
π
1989
π
John Wiley and Sons
π
French
β 636 KB
T cell activation by monoclonal antibodi
β
Hans JΓΌRgen Schlitt; Roland Kurrle; Kurt Wonigeit
π
Article
π
1989
π
John Wiley and Sons
π
English
β 754 KB
Cascade modulation by anti-tumor necrosi
β
Christiane Ferran; Michel Dy; Kathleen Sheehan; Robert Schreiber; Georges Grau;
π
Article
π
1991
π
John Wiley and Sons
π
English
β 513 KB